Maryam Teimouri

Dr. Maryam Teimouri

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2023 in Iranian Journal of Veterinary Medicine
Verified
Journal Article
Open access
PDF file
MSMonireh Shahsavari
Monireh Shahsavari
PNPirasteh Norouzi
Pirasteh Norouzi
HKHamid Kalalianmoghaddam
Hamid Kalalianmoghaddam
MTMaryam Teimouri
Maryam Teimouri
Background: Oxidative stress and inflammation are strictly connected, and both perform an important role in the pathogenesis of diabetes mellitus (DM).Objectives: This research aimed to investigate the potential protective effect of kudzu root against oxidative stress and inflammation in a streptozotocin (STZ)-induced DM animal model.Methods: DM was induced in male Wistar rats by intraperitoneal injection of STZ (50 mg/kg body weight). The kudzu root (100 mg/kg BW) was administered orally after 1 week of STZ administration in diabetic animals (for 6 weeks).Results: The diabetic animals exhibited a significant increase in fasting blood glucose, tumor necrosis factor-alpha, and malondialdehyde levels. However, they exhibited a significant decrease in plasma insulin level, superoxide dismutase, and glutathione peroxidase activity. Administration of kudzu root to diabetic animals reversed these effects.Conclusion: The current study indicated that kudzu root has potent antidiabetic properties, likely through its anti-inflammatory and anti-oxidative properties in the STZ-diabetic rat model.

8 August 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
AAAnita Aminzadeh
Anita Aminzadeh
NANazanin Azmi-Naei
Nazanin Azmi-Naei
MTMaryam Teimouri
Maryam Teimouri
MRMarzieh Rohani-Rasaf
Marzieh Rohani-Rasaf
Background: Simple and cost-effective biochemical markers are still very useful for predicting severity and mortality in COVID-19 patients. This study investigates the association of some inflammatory and also non-invasive biochemical indices of liver function and critical care outcomes of COVID-19 patients. Methods: In this cross-sectional study, a total of 2232 hospitalized COVID-19 patients, regardless of the presence of underlying liver diseases, were followed. Based on the laboratory results at the time of admission, five indices—FIB-4 (Fibrosis-4), NLR (Neutrophil to Lymphocyte Ratio), APRI (Aspartate Aminotransferase to Platelet Ratio), ALRI (Aspartate Aminotransferase to Lymphocyte Ratio), and SII (Systemic Immune-Inflammation)—were calculated. Results: According to the results of multivariate regression, all five indices were predictors of mortality and severity in COVID-19 patients after adjusting for age, sex, comorbidities and BMI. The odds ratios for FIB-4, NLR, APRI, ALRI, and SII to predict mortality were 1.14 (1.07–1.21), 1.07 (1.04–1.1), 1.28 (1.12–1.46), 2.44 (1.76–3.38), and 1.57 (1.13–2.17), respectively. For predicting severity, the odds ratios were 1.22 (1.15–1.30), 1.09 (1.06–1.11), 1.78 (1.44–2.21), 1.73 (1.41–2.14), and 1.27 (1.04–1.57), respectively. Additionally, based on the AUC results, FIB-4 and NLR indices demonstrated the best performance in predicting COVID-19 mortality and severity, respectively. Conclusions: Our results show that the non-invasive biochemical indices of liver function, NLR, and SII can be useful as early predictors of severity and mortality in COVID-19 patients.